Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: Implications for inflammatory demyelinating disease

Matrix Biology

Volumn 32, Issue 3-4, 2013, Pages 160-168

  Winkler, Clayton W ^a   Foster, Scott C ^a   Itakura, Asako ^b   Matsumoto, Steven G ^a,c   Asari, Akira ^d   McCarty, Owen J T ^b   Sherman, Larry S ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Hyaluronan Research Institute Inc   (Japan)

Author keywords

CD44; Endothelial cell; Hyaluronan; Myelin; Toll like receptor

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MESSENGER RNA; OLIGOSACCHARIDE; TETRASACCHARIDE; TOLL LIKE RECEPTOR 4;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD44; BRAIN; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HYALURONIC ACID; LEUKOCYTE ROLLING; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICROVESSELS; OLIGOSACCHARIDES; TOLL-LIKE RECEPTOR 4;

EID: 84876847258     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.01.002     Document Type: Article

References (58)

1. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993, 177:57-68.
2. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
3. Brennan F.R., O'Neill J.K., Allen S.J., Butter C., Nuki G., Baker D. CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 1999, 98:427-435.
4. Brocke S., Piercy C., Steinman L., Weissman I.L., Veromaa T. Antibodies to CD44 and integrin alpha4, but not l-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6896-6901.
5. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Small hyaluronan oligosaccharides induce inflammation by engaging both Toll-like-4 and CD44 receptors in human chondrocytes. Biochem. Pharmacol. 2010, 80:480-490.
6. Campo G.M., Avenoso A., D'Ascola A., Scuruchi M., Prestipino V., Nastasi G., Calatroni A., Campo S. The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J. Cell. Biochem. 2012, 113:1852-1867.
7. David-Raoudi M., Tranchepain F., Deschrevel B., Vincent J.C., Bogdanowicz P., Boumediene K., Pujol J.P. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen. 2008, 16:274-287.
8. DeGrendele H.C., Estess P., Picker L.J., Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 1996, 183:1119-1130.
9. DeGrendele H.C., Estess P., Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997, 278:672-675.
10. Deli M.A., Sakaguchi S., Nakaoke R., Abraham C.S., Takahata H., Kopacek J., Shigematsu K., Katamine S., Niwa M. PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C). Neuroreport 2000, 11:3931-3936.
11. Doring A., Wild M., Vestweber D., Deutsch U., Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 2007, 179:8470-8479.
12. Gelman A.E., Zhang J., Choi Y., Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 2004, 172:6065-6073.
13. Girish K.S., Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 2007, 80:1921-1943.
14. Gonzalez-Navajas J.M., Fine S., Law J., Datta S.K., Nguyen K.P., Yu M., Corr M., Katakura K., Eckman L., Lee J., Raz E. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J. Clin. Invest. 2010, 120:570-581.
15. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
16. Heng B.C., Gribbon P.M., Day A.J., Hardingham T.E. Hyaluronan binding to link module of TSG-6 and to G1 domain of aggrecan is differently regulated by pH. J. Biol. Chem. 2008, 283:32294-32301.
17. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., Noble P.W. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
18. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 2007, 23:435-461.
19. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
20. Kennedy C.I., Diegelmann R.F., Haynes J.H., Yager D.R. Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts. J. Pediatr. Surg. 2000, 35:874-879.
21. Kerfoot S.M., Norman M.U., Lapointe B.M., Bonder C.S., Zbytnuik L., Kubes P. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:6225-6234.
22. Komai-Koma M., Jones L., Ogg G.S., Xu D., Liew F.Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3029-3034.
23. Kuerten S., Lehmann P.V. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?. J. Interferon Cytokine Res. 2011, 31:907-916.
24. Laman J.D., Maassen C.B., Schellekens M.M., Visser L., Kap M., de Jong E., van Puijenbroek M., van Stipdonk M.J., van Meurs M., Schwarzler C., Gunthert U. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult. Scler. 1998, 4:147-153.
25. Lesley J., Gal I., Mahoney D.J., Cordell M.R., Rugg M.S., Hyman R., Day A.J., Mikecz K. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J. Biol. Chem. 2004, 279:25745-25754.
26. Liu J.Q., Carl J.W., Joshi P.S., RayChaudhury A., Pu X.A., Shi F.D., Bai X.F. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:6227-6235.
27. Lokeshwar V.B., Iida N., Bourguignon L.Y. The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J. Biol. Chem. 1996, 271:23853-23864.
28. Mayer W.E., Uinuk-Ool T., Tichy H., Gartland L.A., Klein J., Cooper M.D. Isolation and characterization of lymphocyte-like cells from a lamprey. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14350-14355.
29. Milner C.M., Day A.J. TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci. 2003, 116:1863-1873.
30. Nandi A., Estess P., Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation. Immunity 2004, 20:455-465.
31. Nedvetzki S., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., Huang J.F., Neudecker B.A., Wang F.S., Turley E.A., Naor D. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18081-18086.
32. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002, 21:25-29.
33. Nylander A., Hafler D.A. Multiple sclerosis. J. Clin. Invest. 2012, 122:1180-1188.
34. Pilarski L.M., Miszta H., Turley E.A. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol. 1993, 150:4292-4302.
35. Polman C.H., O'Connor P.W., Havrdova E., Hutchinson M., Kappos L., Miller D.H., Phillips J.T., Lublin F.D., Giovannoni G., Wajgt A., Toal M., Lynn F., Panzara M.A., Sandrock A.W., AFFIRM Investigators A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2006, 354:899-910.
36. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4:33-45.
37. Protin U., Schweighoffer T., Jochum W., Hilberg F. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 1999, 163:4917-4923.
38. Pure E., Cuff C.A. A crucial role for CD44 in inflammation. Trends Mol. Med. 2001, 7:213-221.
39. Sampson P.M., Rochester C.L., Freundlich B., Elias J.A. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J. Clin. Invest. 1992, 90:1492-1503.
40. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 2006, 177:1272-1281.
41. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 2006, 65:124-141.
42. Sherman L., Sleeman J., Herrlich P., Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol. 1994, 6:726-733.
43. Shimada M., Yanai Y., Okazaki T., Noma N., Kawashima I., Mori T., Richards J.S. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 2008, 135:2001-2011.
44. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006, 85:699-715.
45. Sugahara K.N., Murai T., Nishinakamura H., Kawashima H., Saya H., Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 2003, 278:32259-32265.
46. Szanto S., Bardos T., Gal I., Glant T.T., Mikecz K. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis Rheum. 2004, 50:3012-3022.
47. Takahashi Y., Li L., Kamiryo M., Asteriou T., Moustakas A., Yamashita H., Heldin P. Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J. Biol. Chem. 2005, 280:24195-24204.
48. Tammi R., MacCallum D., Hascall V.C., Pienimaki J.P., Hyttinen M., Tammi M. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J. Biol. Chem. 1998, 273:28878-28888.
49. Tammi R., Pasonen-Seppanen S., Kolehmainen E., Tammi M. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J. Invest. Dermatol. 2005, 124:898-905.
50. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 2004, 279:17079-17084.
51. Teriete P., Banerji S., Noble M., Blundell C.D., Wright A.J., Pickford A.R., Lowe E., Mahoney D.J., Tammi M.I., Kahmann J.D., Campbell I.D., Day A.J., Jackson D.G. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol. Cell 2004, 13:483-496.
52. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 2002, 195:99-111.
53. Tuohy T.M., Wallingford N., Liu Y., Chan F.H., Rizvi T., Xing R., Bebo B., Rao M.S., Sherman L.S. CD44 overexpression by oligodendrocytes: a novel mouse model of inflammation-independent demyelination and dysmyelination. Glia 2004, 47:335-345.
54. Turley E.A., Noble P.W., Bourguignon L.Y. Signaling properties of hyaluronan receptors. J. Biol. Chem. 2002, 277:4589-4592.
55. Voskuhl R.R., Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001, 7:258-270.
56. Winkler C.W., Foster S.C., Matsumoto S.G., Preston M., Xing R., Bebo B., Banine F., Berny-Lang M.A., Itakura A., McCarty O.J., Sherman L.S. Hyaluronan anchored to activated CD44 on CNS vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitis. J. Biol. Chem. 2012, 287:33237-33251.
57. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992, 356:63-66.
58. Zaman A., Cui Z., Foley J.P., Zhao H., Grimm P.C., Delisser H.M., Savani R.C. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am. J. Respir. Cell Mol. Biol. 2005, 33:447-454.